PALISADE BIO, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Palisade Bio, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2011 to Q2 2024.
  • Palisade Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $358K, a 149% increase year-over-year.
  • Palisade Bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $840K, a 46.1% increase year-over-year.
  • Palisade Bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $606K, a 41.3% decline from 2022.
  • Palisade Bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1.03M, a 45.4% decline from 2021.
  • Palisade Bio, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $1.89M, a 6.11% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $840K $358K +$214K +149% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $626K $113K +$20K +21.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $606K $177K +$91K +106% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 $515K $192K -$60K -23.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $575K $144K -$192K -57.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $767K $93K -$265K -74% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $1.03M $86K -$638K -88.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 $1.67M $252K +$149K +145% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $1.52M $336K -$159K -32.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $1.68M $358K -$211K -37.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $1.89M $724K -$157K -17.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 $2.05M $103K -$561K -84.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $2.61M $495K +$102K +26% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $2.51M $569K +$493K +650% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $2.01M $881K +$762K +638% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 $1.25M $664K +$369K +125% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $883K $393K +$264K +205% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-23
Q1 2020 $619K $75.9K -$262K -77.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $881K $119K +$55.6K +87.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-22
Q3 2019 $825K $295K +$160K +119% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $665K $129K -$68K -34.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $733K $338K +$99.1K +41.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $634K $63.8K -$202K -76% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-27
Q3 2018 $836K $135K -$195K -59.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $1.03M $197K -$455K -69.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $1.49M $239K -$284K -54.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 $1.77M $266K -$313K -54.1% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-22
Q3 2017 $2.08M $330K -$249K -43% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $2.33M $652K -$165K -20.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 $2.5M $522K -$948K -64.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $3.45M $579K -$252K -30.3% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 $3.7M $579K -$226K -28.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $3.92M $817K +$191K +30.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $3.73M $1.47M +$781K +113% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $2.95M $830K Oct 1, 2015 Dec 31, 2015 10-K 2017-03-23
Q3 2015 $805K +$148K +22.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 $626K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 $690K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q3 2014 $657K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q3 2012 $487K -$181K -27.1% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $331K -$728K -68.8% Apr 1, 2012 Jun 30, 2012 10-Q 2012-08-09
Q3 2011 $668K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 $1.06M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.